Schroder Managed Wealth Portfolio Class Z - Income (GBP)
Sell:85.98p
Buy:85.98p
Change:
0.06p
(0.07%)
0.06p
(0.07%)
Prices as at 30 July 2025
Sell:85.98p
Buy:85.98p
Change:
0.06p
(0.07%)
0.06p
(0.07%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 30 July 2025
Sell:85.98p
Buy:85.98p
Change:
0.06p
(0.07%)
0.06p
(0.07%)
Prices as at 30 July 2025
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Asset Allocation
Standard top 10 holdings
IA sector allocation
| Not Classified | 22.74% | |
|---|---|---|
| Non-mutual | 15.54% | |
| Absolute Return | 9.20% | |
| North American Smaller Companies | 6.58% | |
| Specialist | 5.36% | |
| Cash | 5.13% | |
| Fixed Int-Emerging Mkts | 5.06% | |
| UK Equity Income | 4.48% | |
| Currency Sterling | 3.92% | |
| UK All Companies | 3.53% | |
| UK Smaller Companies | 3.25% | |
| Equity-UK | 3.09% | |
| Equity-North America | 2.10% | |
| Global Emerging Markets | 1.73% | |
| Asia Pacific ex Japan | 1.57% | |
| Hedge/Stru Prod - Equity | 1.48% | |
| Equity-Other Specialist | 1.26% | |
| Equity-Pharma Hlth & Biotech | 1.06% | |
| Europe Excluding UK | 1.02% | |
| Equity-India | 1.00% | |
| Equity-Asia Pacific ex Japan | 0.90% |
X-ray top 10 holdings
Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
